MNOV – medicinova, inc. (US:NASDAQ)
Stock Stats
News
12/18
08:05 am
mnov
Low
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
12/18
06:46 am
mnov
Low
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy [Yahoo! Finance]
12/18
06:00 am
mnov
Low
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
12/8
11:41 am
mnov
Neutral
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
12/8
06:00 am
mnov
Medium
MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND
11/12/2025
04:35 pm
mnov
1.0%
BEAT
8/14/2025
05:02 pm
mnov
0.8%
IN-LINE
12/12
06:03 am
mnov
Low
Form EFFECT MEDICINOVA INC
12/5
04:24 pm
mnov
Low
Form S-3 MEDICINOVA INC
11/12
04:35 pm
mnov
Low
Form 10-Q MEDICINOVA INC For: Sep 30
10/1
06:07 am
mnov
Low
Form EFFECT MEDICINOVA INC
Show more
Top News Gainers
4/8 MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) 37.8%
3/12 Form 4 MEDICINOVA INC For: Mar 12 Filed by: IWAKI YUICHI 30.2%
4/9 MediciNova, Inc. (NASDAQ: MNOV) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $11.00 price target on the stock. 26.1%
7/11 MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS 14.5%
3/16 Form 4/A MEDICINOVA INC For: Mar 13 Filed by: Matsuda Kazuko 7.8%
4/23 Q1/2020 3/31/2020 EPS -0.060 ZacksConsensus -0.080 ActVsEst 0.020 - Beat 4.6%
8/23 Form 424B5 MEDICINOVA INC 3.8%
8/20 MediciNova: Leading The Pack In An MS Subtype [Seeking Alpha] 3.5%
5/7 MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the Official Launch of Myelopathy.org in London, United Kingdom 3.1%
1/27 MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in Europe 2.8%
Top News Decliners
10/24 Q3/2019 9/30/2019 EPS -0.050 ZacksConsensus -0.150 ActVsEst 0.100 - Beat -12.8%
4/13 Form 4 MEDICINOVA INC For: Jul 13 Filed by: IWAKI YUICHI -6.7%
8/23 Form EFFECT MEDICINOVA INC -6.7%
3/9 MediciNova Announces Plans to Develop MN-166 (ibudilast) for Severe Pneumonia and Acute Respiratory Distress Syndrome (ARDS) -5.3%
2/17 MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Japan -5.2%
7/24 MediciNova Appoints Kazuko Matsuda to its Board of Directors -4.9%
4/20 MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma -4.8%
8/9 Form S-3 MEDICINOVA INC -4.7%
4/16 Form 8-K MEDICINOVA INC For: Apr 15 -4.4%
9/30 MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in China -3.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3